Aethon Therapeutics’ Post

Aethon Therapeutics reposted this

View organization page for FairJourney Biologics, graphic

18,137 followers

We are delighted to announce Christoph Rader, CTO at Aethon Therapeutics, will be speaking at the 4th Edition of The Antibody Series (Sept 4 - 6, 2024) on "Creating and targeting synthetic neoepitopes on cancer cells". 💡 Discover Christoph Rader's biography and abstract here: https://lnkd.in/euJzgCyc 🎫 Pre-register free for on-demand access to this talk and more: https://lnkd.in/eNd2cBKp 🌎 THE ANTIBODY SERIES (TAS) is the fastest growing antibody event of its kind. TAS brings together industry and academia experts in-person to exchange innovative ideas in antibody discovery and development co-joined by +4,000 registered antibody members online. #neoepitopes #research #antibody #conference #speaker #tas24

  • No alternative text description for this image
Christoph Rader

Chief Technology Officer, Aethon Therapeutics, Inc.

7mo

Looking forward to it. Thank you Paul Parren for the invitation.

To view or add a comment, sign in

Explore topics